RHYTHM PHARMACEUTICALS, INC.
Ticker: 1649904
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 60.11+17.2% | 51.30+5.8% | 48.50+48.3% | 32.70-1.7% | 33.25+14.3% | 29.08+12.0% | 25.97+15.4% | 22.50 |
| Total Income | 60.11+17.2% | 51.30+5.8% | 48.50+48.3% | 32.70-1.7% | 33.25+14.3% | 29.08+12.0% | 25.97+15.4% | 22.50 |
| EXPENSES | ||||||||
| Expenditure | 112.47+8.2% | 103.95+10.8% | 93.80+17.7% | 79.71+3.3% | 77.14+10.9% | 69.56-58.1% | 165.85+149.5% | 66.46 |
| Tax | 0.55+400.0% | 0.11-67.6% | 0.34+325.0% | 0.08+123.5% | -0.34-170.8% | 0.48+60.0% | 0.30-18.9% | 0.37 |
| PROFIT | ||||||||
| PBT | -55.09-4.4% | -52.79-14.0% | -46.30+6.3% | -49.42-12.3% | -43.99-38.4% | -31.78+77.5% | -141.07-222.1% | -43.80 |
| Net Profit | -55.64-5.2% | -52.90-13.4% | -46.63+5.8% | -49.50-13.4% | -43.64-35.3% | -32.26+77.2% | -141.37-220.1% | -44.16 |
| KEY METRICS | ||||||||
| OPM % | -87.11%+12.89pp | -100.00%-6.61pp | -93.39%+6.61pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -92.56%+7.44pp | -100.00%-3.85pp | -96.14%+3.85pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.83-1.2% | -0.82-9.3% | -0.75+7.4% | -0.81-11.0% | -0.73-32.7% | -0.55+76.6% | -2.35-209.2% | -0.76 |
Corporate Events
Board MeetingRYTM
202624Jun
Board Meeting
Annual Meeting of Stockholders results, including the electi…
SEC Filing ↗